Aurinia Pharmaceuticals Inc.
Recent Filings
All 581 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13D/A | — | Mar 25, 2026 |
| 8-K | 8-K | Mar 23, 2026 |
| 4 | FORM 4 | Mar 10, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| SCHEDULE 13D/A | — | Mar 3, 2026 |
| 4 | — | Mar 3, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| TANG KEVIN | — | Purchase | 100,000 @ $11.34 | Aug 1, 2025 |
| Keenan Greg | Chief Medical Officer | Sale | 20,000 @ $10.50 | Aug 1, 2025 |
| Keenan Greg | Chief Medical Officer | Sale | 8,305 @ $8.23 | Mar 7, 2025 |
| Miller Joseph M | Chief Financial Officer | Award / Grant | 114,711 | Mar 4, 2025 |
| Robertson Stephen P. | EVP, General Counsel | Award / Grant | 84,106 | Mar 4, 2025 |
| Greenleaf Peter | Chief Executive Officer | Sale | 164,947 @ $7.92 | Mar 3, 2025 |
| Keenan Greg | Chief Medical Officer | Award / Grant | 62,583 | Mar 3, 2025 |
| Donley Matthew Maxwell | Chief Operating Officer | Sale | 58,991 @ $7.92 | Mar 3, 2025 |
| TANG KEVIN | — | Purchase | 351,962 @ $8.02 | Mar 3, 2025 |
| TANG KEVIN | — | Purchase | 500,000 @ $9.09 | Dec 5, 2024 |